Kalpana Gupta Shekhawat: The Neurobiology of Elevated Homocysteine
Kalpana Gupta Shekhawat, Chairperson at the Functional and Metabolic Medicine Academy, Gurugram, India, shared a post on LinkedIn:
”The Neurobiology of Elevated Homocysteine
Brain health is influenced by far more than genetics and ageing.
Nutrient status, vascular function, inflammation, mitochondrial health, and methylation all play critical roles in maintaining normal neurological function.
Among the laboratory markers that reflect these interconnected processes, homocysteine provides valuable clinical insight.
Homocysteine is an intermediate amino acid formed during methionine metabolism.
Under normal circumstances, it is efficiently recycled through methylation or converted into cysteine with the help of folate, vitamin B12, vitamin B6, and riboflavin.
When these pathways become inefficient, homocysteine accumulates, reflecting impaired methylation and broader metabolic dysfunction.
From a functional medicine perspective, an elevated homocysteine level is more than an abnormal laboratory finding—it is an important clinical signal.
Rather than asking how to lower the value, the more meaningful question is:
What is driving it?
A growing body of research has shown that elevated homocysteine can adversely affect the brain through multiple mechanisms.
It promotes excitotoxicity by overstimulating NMDA receptors, increases oxidative stress, impairs mitochondrial function, damages the vascular endothelium, and disrupts the integrity of the blood–brain barrier.
It also contributes to persistent neuroinflammation, creating an environment that may accelerate cognitive decline and increase the risk of stroke, vascular dementia, depression, and other neurological disorders.
Importantly, elevated homocysteine should not be attributed solely to MTHFR variants.
Nutritional deficiencies, chronic inflammation, hypothyroidism, renal dysfunction, certain medications, excessive alcohol intake, and poor dietary patterns can all impair homocysteine metabolism.
Identifying these contributors is essential for developing an effective treatment strategy.
For clinicians, homocysteine offers an opportunity to identify metabolic dysfunction before more significant neurological consequences develop.
Evaluating nutritional status, supporting methylation, reducing inflammation, and optimizing lifestyle factors can improve homocysteine metabolism while addressing the underlying cause.
Rather than viewing homocysteine as an isolated laboratory value, it should be considered within the broader context of metabolic health, where it can provide meaningful insights into brain function, cognitive resilience, and long-term neurological outcomes.”
Stay updated with Hemostasis Today.
-
Aug 2, 2026, 23:07Akshat Jain: Redefining Hemophilia Readiness in Mexico
-
Aug 2, 2026, 16:24Satish Medakkar: The Importance of Early Recognition in Atypical Hemolytic Uremic Syndrome
-
Aug 2, 2026, 16:07Mirjavad Mammadov: Understanding the Thrombotic Paradox of Heparin Therapy
-
Aug 2, 2026, 15:49Munira Borhany: Advancing Equity in Women’s Hematological Care
-
Aug 2, 2026, 14:54Every Second Counts: How CPR and AEDs Can Save a Life – American Heart Association
-
Aug 2, 2026, 14:38New French Guidelines for Acquired Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Aug 2, 2026, 14:36Sankesh Mehta: Restoring Venous Patency Through Mechanical Thrombectomy
-
Aug 2, 2026, 14:17Douglas Tavares: How Do We Get More People To Donate?
-
Aug 2, 2026, 14:15Saleh Shamse Basha: Severe Neonatal Anemia – When the Analyzer Tells a Story Before the Slide Does